WHITEHAWK THERAPEUTICS, INC. Number of Operating Segments
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Number of Operating Segments of 1 Segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-08-06
- WHITEHAWK THERAPEUTICS, INC. number of operating segments for the quarter ending 2026-03-31 was 1.00 Segment.
- WHITEHAWK THERAPEUTICS, INC. number of operating segments for the quarter ending 2022-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- WHITEHAWK THERAPEUTICS, INC. number of operating segments for the quarter ending 2021-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- WHITEHAWK THERAPEUTICS, INC. number of operating segments for the quarter ending 2020-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- WHITEHAWK THERAPEUTICS, INC. number of operating segments for fiscal 2025 was 1.00 Segment.
- WHITEHAWK THERAPEUTICS, INC. number of operating segments for fiscal 2021 was 1.00 Segment, a 0.00% change from fiscal 2020.
- WHITEHAWK THERAPEUTICS, INC. number of operating segments for fiscal 2020 was 1.00 Segment, a 0.00% change from fiscal 2019.
- WHITEHAWK THERAPEUTICS, INC. number of operating segments for fiscal 2019 was 1.00 Segment, a 0.00% change from fiscal 2018.
Segment
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 Segment 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 1.00 Segment 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 1.00 Segment 10-K · filed 2026-03-12 | |||
| 2025-09-30 | 1.00 Segment 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 1.00 Segment 10-Q · filed 2025-08-07 | |||
| 2022-03-31 | 1.00 Segment 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | 1.00 Segment 10-K · filed 2022-03-17 | |||
| 2021-09-30 | 1.00 Segment 10-Q · filed 2021-11-10 | |||
| 2021-06-30 | 1.00 Segment 10-Q · filed 2021-08-11 | |||
| 2021-03-31 | 1.00 Segment 10-Q · filed 2021-05-17 | |||
| 2020-12-31 | 1.00 Segment 10-K · filed 2021-03-11 | |||
| 2020-09-30 | 1.00 Segment 10-Q · filed 2020-11-10 | |||
| 2020-06-30 | 1.00 Segment 10-Q · filed 2020-08-12 | |||
| 2020-03-31 | 1.00 Segment 10-Q · filed 2020-05-07 | |||
| 2019-12-31 | 1.00 Segment 10-K · filed 2020-03-16 | |||
| 2019-09-30 | 1.00 Segment 10-Q · filed 2019-11-07 | |||
| 2019-06-30 | 1.00 Segment 10-Q · filed 2019-08-08 | |||
| 2019-03-31 | 1.00 Segment 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | 1.00 Segment 10-K · filed 2019-03-07 | |||
| 2018-09-30 | 1.00 Segment 10-Q · filed 2018-11-07 | |||
| 2018-06-30 | 1.00 Segment 10-Q · filed 2018-08-14 | |||
| 2018-03-31 | 1.00 Segment 10-Q · filed 2018-05-15 | |||
| 2017-12-31 | 1.00 Segment 10-K · filed 2018-03-15 | |||
| 2017-09-30 | 1.00 Segment 10-Q · filed 2017-11-13 | |||
| 2017-06-30 | 1.00 Segment 10-Q · filed 2017-08-10 | |||
| 2017-03-31 | 1.00 Segment 10-Q · filed 2017-05-15 |
segment
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-03-28 | |||
| 2024-09-30 | 1.00 segment 10-Q · filed 2024-11-06 | |||
| 2024-06-30 | 1.00 segment 10-Q · filed 2024-08-07 | |||
| 2024-03-31 | 1.00 segment 10-Q · filed 2024-05-08 | |||
| 2023-12-31 | 1.00 segment 10-K · filed 2024-03-13 | |||
| 2023-09-30 | 1.00 segment 10-Q · filed 2023-11-08 | |||
| 2023-06-30 | 1.00 segment 10-Q · filed 2023-08-09 | |||
| 2023-03-31 | 1.00 segment 10-Q · filed 2023-05-10 | |||
| 2022-12-31 | 1.00 segment 10-K · filed 2023-03-29 | |||
| 2022-09-30 | 1.00 segment 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | 1.00 segment 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |